Home/Pipeline/Autoimmune Diagnostics (Immco)

Autoimmune Diagnostics (Immco)

Autoimmune disorders

Approved/CommercialReference laboratory services

Key Facts

Indication

Autoimmune disorders

Phase

Approved/Commercial

Status

Reference laboratory services

Company

Trinity Biotech

About Trinity Biotech

Trinity Biotech is a publicly traded diagnostics company focused on transforming healthcare through innovative testing solutions. The company has achieved significant milestones, including regaining compliance with Nasdaq listing requirements and securing regulatory approvals for offshored manufacturing of its flagship HIV test. With a diversified portfolio spanning infectious disease, autoimmune, hemoglobin, and clinical chemistry testing, Trinity Biotech aims to improve patient outcomes globally while executing a strategic transformation to enhance financial performance.

View full company profile

Therapeutic Areas

Infectious Diseases Autoimmune Disorders Diabetes Hemoglobinopathies Clinical Chemistry

Other Autoimmune disorders Drugs

Drug	Company	Phase	Status
Humira	Royalty Pharma	Commercial	Active
Immunomodulation Programs	Fosun Pharma	Various Phases	Active
Adalimumab Biosimilar	Glenmark Pharmaceuticals	Phase 3	Filed
Autoimmune Disease Programs	TScan Therapeutics	Discovery	Target Discovery
TYK2 Pseudokinase Inhibitor	A2A Pharma	Preclinical	Preclinical Development